Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb;45(2):e12953.
doi: 10.1111/pim.12953. Epub 2022 Oct 17.

Emerging and re-emerging fungal threats in Africa

Affiliations
Review

Emerging and re-emerging fungal threats in Africa

Rachael Dangarembizi et al. Parasite Immunol. 2023 Feb.

Abstract

The emergence of deadly fungal infections in Africa is primarily driven by a disproportionately high burden of human immunodeficiency virus (HIV) infections, lack of access to quality health care, and the unavailability of effective antifungal drugs. Immunocompromised people in Africa are therefore at high risk of infection from opportunistic fungal pathogens such as Cryptococcus neoformans and Pneumocystis jirovecii, which are associated with high morbidity, mortality, and related socioeconomic impacts. Other emerging fungal threats include Emergomyces spp., Histoplasma spp., Blastomyces spp., and healthcare-associated multi-drug resistant Candida auris. Socioeconomic development and the Covid-19 pandemic may influence shifts in epidemiology of invasive fungal diseases on the continent. This review discusses the epidemiology, clinical manifestations, and current management strategies available for these emerging fungal diseases in Africa. We also discuss gaps in knowledge, policy, and research to inform future efforts at managing these fungal threats.

Keywords: dimorphic fungal pathogens; emerging fungi; fungal pathogens; opportunistic fungal infections.

PubMed Disclaimer

Conflict of interest statement

All authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Annual incidence of cryptococcal infections in Africa (modified from 13 )
FIGURE 2
FIGURE 2
(A) A 39‐year‐old woman, HIV‐positive, failing antiretroviral therapy: CD4 count 105 cells/mm3, HIV viral load log 5 copies/ml. Presented with weight loss and night sweats, worsening dyspnoea, myalgia, and diarrhoea over prior few days. Started on empiric treatment for PCP which was discontinued when Covid‐19 diagnosis confirmed by PCR the day after admission. There was a good response to corticosteroids and supportive management. Chest x‐ray shows bilateral interstitial infiltrates with lower zone ground glass opacification. (B) 51‐year‐old man, newly diagnosed HIV with CD4 count 49 cells/mm3. P. jirovecii confirmed by immunofluorescent staining of induced sputum. Initial chest x‐ray shows perihilar interstitial infiltrates with areas of confluence.

References

    1. Robert VA, Casadevall A. Vertebrate endothermy restricts most fungi as potential pathogens. J Infect Dis. 2009;200(10):1623‐1626. - PubMed
    1. Bergman A, Casadevall A. Mammalian endothermy optimally restricts fungi and metabolic costs. MBio. 2010;1(5):e00212‐e00210. - PMC - PubMed
    1. Kwon‐Chung KJ, Bennett JE . Cryptococcosis. In: Medical Mycology. Lea & Febiger; 1992;397‐446.
    1. Nnadi NE, Carter DA. Climate change and the emergence of fungal pathogens. PLoS Pathog. 2021;17(4):e1009503. - PMC - PubMed
    1. Casadevall A, Kontoyiannis DP, Robert V. On the emergence of Candida auris: climate change, azoles, swamps, and birds. MBio. 2019;10(4):e01397‐e01319. - PMC - PubMed

Publication types

Substances